While reporting financial results for the second quarter on Wednesday, medical technology company Integra LifeSciences Holdings Corp. (IART) trimmed its adjusted earnings and revenue guidance for the full-year 2022. The company also issued outlook for the third quarter.
from RTT - Earnings https://ift.tt/oSmJsrK
via IFTTT
No comments:
Post a Comment